ORAI1 and cancer: Again, the significantly higher proliferation rate observed with STIM1-OE cells over that of EpCAM(+)CD133(+) cells overexpressing both STIM1 and Orai1 (present data) confirms the poor prognosis of several cancer types with overexpressed STIM1 [54–56].